Drug Profile
Research programme: pain therapeutics - Biogen/Evotec SE
Latest Information Update: 07 Oct 2019
Price :
$50
*
At a glance
- Originator Convergence Pharmaceuticals; Evotec AG
- Developer Biogen; Evotec SE
- Class Analgesics
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain